Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 2/12/2026

Left Hemicolectomy with D3 Lymphadenectomy: Evidence‑Based Guidelines

Preoperative Assessment

  • Colonoscopy is required to locate the tumor and exclude synchronous lesions (American Society of Colon and Rectal Surgeons) 1
  • Contrast‑enhanced CT of the chest, abdomen, and pelvis should be performed to detect distant metastases and delineate tumor extent (American Society of Colon and Rectal Surgeons) 1
  • Baseline laboratory work‑up—including carcinoembryonic antigen, complete blood count, and routine biochemistry—is recommended (American Society of Colon and Rectal Surgeons) 1
  • MRI is advised when the disease is locally advanced to better characterize involvement of adjacent structures (American Society of Colon and Rectal Surgeons) 1

Surgical Technique Recommendations

  • A laparoscopic approach is recommended when surgical expertise is available, as it reduces morbidity while providing oncologic outcomes comparable to open surgery (American Society of Colon and Rectal Surgeons) 1
  • The operative goal is to harvest at least 12 lymph nodes to ensure accurate pathological staging (American Society of Colon and Rectal Surgeons) 1

Pathologic Evaluation and Staging

  • TNM staging must follow the UICC classification system (American Society of Colon and Rectal Surgeons) 1
  • Pathology should assess high‑risk features such as lymphovascular invasion, perineural invasion, poor differentiation, and insufficient nodal harvest (American Society of Colon and Rectal Surgeons) 1
  • Microsatellite instability (MSI) or mismatch repair (MMR) status should be determined in stage II disease to guide adjuvant therapy decisions (American Society of Colon and Rectal Surgeons) 1

Oncologic Outcomes and Risk Factors

  • Harvesting fewer than 12 lymph nodes is associated with understaging and is considered a high‑risk factor that may necessitate adjuvant therapy (American Society of Colon and Rectal Surgeons) 1
  • Omitting D3 lymphadenectomy in T3/T4 tumors compromises oncologic outcomes; Asian guidelines recommend routine extended lymphadenectomy for such advanced tumors (American Society of Colon and Rectal Surgeons) 1
  • Inadequate resection margins jeopardize oncologic adequacy (Praxis Medical Insights) 3